13,797
Views
38
CrossRef citations to date
0
Altmetric
Review

Cognitive behavior therapy for health anxiety: systematic review and meta-analysis of clinical efficacy and health economic outcomes

ORCID Icon & ORCID Icon
Pages 663-676 | Received 20 Aug 2019, Accepted 07 Dec 2019, Published online: 20 Dec 2019

References

  • Sunderland M, Newby JM, Andrews G. Health anxiety in Australia: prevalence, comorbidity, disability and service use. Br J Psychiatry. 2013;202(1):56–61.
  • Tyrer P, Cooper S, Tyrer H, et al. Increase in the prevalence of health anxiety in medical clinics: possible cyberchondria. Int J Soc Psychiatry. 2019;65(7–8):566–569.
  • Fink P, Ørnbøl E, Christensen Sparle K. The outcome of health anxiety in primary care. A two-year follow-up study on health care costs and self-rated health. PLoS One. 2010;5(3):e9873.
  • Craske MG, Rauch SL, Ursano R, et al. What is an anxiety disorder? Depress Anxiety. 2009;26:1066–1085.
  • Marcus DK, Church SE. Are dysfunctional beliefs about illness unique to hypochondriasis? J Psychosom Res. 2003;54(6):543–547.
  • Neng J, Weck F. Attribution of somatic symptoms in hypochondriasis. Clin Psychol Psychother. 2015;22(2):116–124.
  • Owens KMB, Asmundson GJG, Hadjistavropoulos T, et al. Attentional bias toward illness threat in individuals with elevated health anxiety. Cognit Ther Res. 2004;28(1):57–66.
  • Krautwurst S, Gerlach AL, Gomille L, et al. Health anxiety–an indicator of higher interoceptive sensitivity? J Behav Ther Exp Psychiatry. 2014;45(2):303–309.
  • Deacon B, Abramowitz JS. Is hypochondriasis related to obsessive-compulsive disorder, panic disorder, or both? an empirical evaluation. J Cogn Psychother. 2008;22(2):115–127.
  • Haenen MA, de Jong PJ, Schmidt AJM, et al. Hypochondriacs’ estimation of negative outcomes: domain-specificity and responsiveness to reassuring and alarming information. Behav Res Ther. 2000;38(8):819–833.
  • Hedman E, Ljótsson B, Andersson E, et al. Psychometric properties of internet-administered measures of health anxiety: an investigation of the health anxiety inventory, the illness attitude scales, and the whiteley index. J Anxiety Disord. 2015;31:32–37.
  • Abramowitz JS, Moore EL. An experimental analysis of hypochondriasis. Behav Res Ther. 2007;45(3):413–424.
  • Salkovskis PM, Warwick HM. Morbid preoccupations, health anxiety and reassurance: A cognitive-behavioural approach to hypochondriasis. Behav Res Ther. 1986;24(5):597–602.
  • Olatunji BO, Etzel EN, Tomarken AJ, et al. The effects of safety behaviors on health anxiety: an experimental investigation. Behav Res Ther. 2011;49(11):719–728.
  • Weck F, Neng JM, Schwind J, et al. Exposure therapy changes dysfunctional evaluations of somatic symptoms in patients with hypochondriasis (health anxiety). A randomized controlled trial. J Anxiety Disord. 2015;34:1–7.
  • Louw K-A, Hoare J, Stein D. J. Pharmacological treatments for hypochondriasis: a review. Curr Psychiatry Rev. 2014;10(1):70–74.
  • Walker J, Vincent N, Furer P, et al. Treatment preference in hypochondriasis. J Behav Ther Exp Psychiatry. 1999;30(4):251–258.
  • Furer P, Walker JR. Treatment of hypochondriasis with exposure. J Contemp Psychother. 2005;35(3):251–267.
  • Bennett-Levy J, Westbrook D, Fennell M, et al. Behavioural experiments: historical and conceptual underpinnings. In: Bennett-Levy J, Butler G, Fennell M, et al., editors. Oxford guide to behavioural experiments in cognitive therapy. Oxford, UK: Oxford University Press; 2004. p. 1–20.
  • Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007;69(9):881–888.
  • Thomson AB, Page LA. Psychotherapies for hypochondriasis. Cochrane Database Syst Rev. 2007;(4):CD006520.
  • Bouman TK. Psychological treatments for hypochondriasis: a narrative review. Curr Psychiatry Rev. 2014;10(1):58–69.
  • Olatunji BO, Kauffman BY, Meltzer S, et al. Cognitive-behavioral therapy for hypochondriasis/health anxiety: A meta-analysis of treatment outcome and moderators. Behav Res Ther. 2014;58:65–74.
  • Cooper K, Gregory JD, Walker I, et al. Cognitive behaviour therapy for health anxiety: A systematic review and meta-analysis. Behav Cogn Psychother. 2017;45(2):110–123.
  • Liu J, Gill NS, Teodorczuk A, et al. The efficacy of cognitive behavioural therapy in somatoform disorders and medically unexplained physical symptoms: A meta-analysis of randomized controlled trials. J Affect Disord. 2019;245:98–112.
  • Lilienfeld SO, McKay D, Hollon SD. Why randomised controlled trials of psychological treatments are still essential. Lancet Psychiatry. 2018;5(7):536–538.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
  • Konnopka A, Schaefert R, Heinrich S, et al. Economics of medically unexplained symptoms: a systematic review of the literature. Psychother Psychosom. 2012;81(5):265–275.
  • Bramer WM, Giustini D, de Jonge GB, et al. De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc. 2016;104(3):240–243.
  • Dimsdale JE, Creed F, Escobar J, et al. Somatic symptom disorder: an important change in DSM. J Psychosom Res. 2013;75(3):223–228.
  • Fink P. Syndromes of bodily distress or functional somatic syndromes - where are we heading. Lecture on the occasion of receiving the Alison Creed award 2017. J Psychosom Res. 2017;97:127–130.
  • Lipsey MW, Wilson DB. Practical meta-analysis. Thousand Oaks, CA: Sage Publications, Inc; 2001.
  • Warwick HM, Clark DM, Cobb AM, et al. A controlled trial of cognitive-behavioural treatment of hypochondriasis. Br J Psychiatry. 1996;169(2):189–195.
  • Clark DM, Salkovskis PM, Hackmann A, et al. Two psychological treatments for hypochondriasis: A randomised controlled trial. Br J Psychiatry. 1998;173:218–225.
  • Weck F, Neng JM, Richtberg S, et al. Cognitive therapy versus exposure therapy for hypochondriasis (health anxiety): A randomized controlled trial. J Consult Clin Psychol. 2015;83(4):665–676.
  • Skjernov M. Group cognitive behaviour therapy for severe health anxiety: A randomised controlled trial. Copenhagen, Denmark: University of Copenhagen; 2017.
  • Fallon BA, Ahern DK, Pavlicova M, et al. A randomized controlled trial of medication and cognitive-behavioral therapy for hypochondriasis. Am J Psychiatry. 2017;174(8):756–764.
  • Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59(1):12–19.
  • Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
  • R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2016.
  • Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1–48.
  • Hedges LV. Distribution theory for Glass’s estimator of effect size and related estimators. J Educ Behav Stat. 1981;6(2):107–128.
  • Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
  • Buwalda FM, Bouman TK, van Duijn MA. Psychoeducation for hypochondriasis: a comparison of a cognitive-behavioural approach and a problem-solving approach. Behav Res Ther. 2007;45(5):887–899.
  • Salkovskis PM, Rimes K, Warwick H, et al. The health anxiety inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med. 2002;32(5):843–853.
  • Kellner R. Somatization and hypochondriasis. New York: Praeger Publishers; 1986.
  • Muraki E, Hombo CM, Lee YW. Equating and linking of performance assessments. Appl Psychol Meas. 2000;24(4):325–337.
  • Hedman E, Axelsson E, Andersson E, et al. Exposure-based cognitive-behavioural therapy via the internet and as bibliotherapy for somatic symptom disorder and illness anxiety disorder: randomised controlled trial. Br J Psychiatry. 2016;209(5):407–413.
  • Lovas DA, Barsky AJ. Mindfulness-based cognitive therapy for hypochondriasis, or severe health anxiety: a pilot study. J Anxiety Disord. 2010;24(8):931–935.
  • Wahl I, Löwe B, Bjorner JB, et al. Standardization of depression measurement: a common metric was developed for 11 self-report depression measures. J Clin Epidemiol. 2014;67(1):73–86.
  • Svanborg P, Åsberg M. A new self-rating scale for depression and anxiety states based on the comprehensive psychopathological rating scale. Acta Psychiatr Scand. 1994;89(1):21–28.
  • Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res. 1982;17(1):37–49.
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
  • Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
  • Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455–463.
  • Axelsson E, Andersson E, Ljótsson B, et al. Cost-effectiveness and long-term follow-up of three forms of minimal-contact cognitive behaviour therapy for severe health anxiety: results from a randomised controlled trial. Behav Res Ther. 2018;107:95–105.
  • Bovell CV. Randomized controlled feasibility trial of a self-help book for health anxiety. Regina, Canada: University of Regina; 2012.
  • Visser S, Bouman TK. The treatment of hypochondriasis: exposure plus response prevention vs cognitive therapy. Behav Res Ther. 2001;39(4):423–442.
  • Bourgault-Fagnou MD, Hadjistavropoulos HD. A randomized trial of two forms of cognitive behaviour therapy for an older adult population with subclinical health anxiety. Cogn Behav Ther. 2013;42(1):31–44.
  • Tyrer P, Cooper S, Salkovskis P, et al. Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial. Lancet. 2014;383(9913):219–225.
  • Morriss R, Patel S, Malins S, et al. Clinical and economic outcomes of remotely delivered cognitive behaviour therapy versus treatment as usual for repeat unscheduled care users with severe health anxiety: a multicentre randomised controlled trial. BMC Med. 2019;17(1):16.
  • Weck F, Neng JM. Response and remission after cognitive and exposure therapy for hypochondriasis. J Nerv Ment Dis. 2015;203(11):883–885.
  • Hedman E, Andersson G, Andersson E, et al. Internet-based cognitive-behavioural therapy for severe health anxiety: randomised controlled trial. Br J Psychiatry. 2011;198(3):230–236.
  • Greeven A, van Balkom AJ, Visser S, et al. Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial. Am J Psychiatry. 2007;164(1):91–99.
  • Sørensen P, Birket-Smith M, Wattar U, et al. A randomized clinical trial of cognitive behavioural therapy versus short-term psychodynamic psychotherapy versus no intervention for patients with hypochondriasis. Psychol Med. 2011;41(2):431–441.
  • Hedman E, Axelsson E, Görling A, et al. Internet-delivered exposure-based cognitive-behavioural therapy and behavioural stress management for severe health anxiety: randomised controlled trial. Br J Psychiatry. 2014;205(4):307–314.
  • Newby JM, Smith J, Uppal S, et al. Internet-based cognitive behavioral therapy versus psychoeducation control for illness anxiety disorder and somatic symptom disorder: A randomized controlled trial. J Consult Clin Psychol. 2018;86(1):89–98.
  • Hedman E, Andersson E, Lindefors N, et al. Cost-effectiveness and long-term effectiveness of internet-based cognitive behaviour therapy for severe health anxiety. Psychol Med. 2013;43(2):363–374.
  • Barsky AJ, Ahern DK. Cognitive behavior therapy for hypochondriasis: a randomized controlled trial. JAMA. 2004;291(12):1464–1470.
  • Seivewright H, Green J, Salkovskis P, et al. Cognitive-behavioural therapy for health anxiety in a genitourinary medicine clinic: randomised controlled trial. Br J Psychiatry. 2008;193(4):332–337.
  • Hedman E, Andersson E, Ljótsson B, et al. Cost effectiveness of internet-based cognitive behaviour therapy and behavioural stress management for severe health anxiety. BMJ Open. 2016;6(4):e009327.
  • Axelsson E, Lindsäter E, Ljótsson B, et al. The 12-item self-report World Health Organization Disability Assessment Schedule (WHODAS) 2.0 administered via the internet to individuals with anxiety and stress disorders: a psychometric investigation based on data from two clinical trials. JMIR Ment Health. 2017;4(4):e58.
  • Mataix-Cols D, Fernandez de la Cruz L, Nordsletten AE, et al. Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder. World Psychiatry. 2016;15(1):80–88.